نتائج البحث - Talat Almukhtar

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

    RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY حسب Susan B. Bressler, Michele Melia, Adam R. Glassman, Talat Almukhtar, Lee M. Jampol, Michel Shami, Brian B. Berger, Neil M. Bressler

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Macular Edema After Cataract Surgery in Eyes Without Preoperative Central-Involved Diabetic Macular Edema

    Macular Edema After Cataract Surgery in Eyes Without Preoperative Central-Involved Diabetic Macular Edema حسب Carl W. Baker, Talat Almukhtar, Neil M. Bressler, Adam R. Glassman, Sandeep Grover, Stephen J. Kim, T. Murtha, Michael Rauser, Cynthia R. Stockdale

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment

    Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment حسب Susan B. Bressler, Talat Almukhtar, Anjali M. Bhorade, Neil M. Bressler, Adam R. Glassman, Susan S. Huang, Lee M. Jampol, Judy E. Kim, Michele Melia

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA

    TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA حسب Scott M. Friedman, Talat Almukhtar, Carl W. Baker, Adam R. Glassman, Michael J. Elman, Neil M. Bressler, Manvi P. Maker, Lee M. Jampol, Michele Melia

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema

    Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema حسب Susan B. Bressler, Adam R. Glassman, Talat Almukhtar, Neil M. Bressler, Frederick L. Ferris, Joseph M. Googe, Shailesh Kumar Gupta, Lee M. Jampol, Michele Melia, John A. Wells

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: